1102P The phase III NETTER-1 study of 177Lu-DOTATATE in patients with midgut neuroendocrine tumours: Further survival analyses
Autor: | Ruszniewski, P.B., Caplin, M.E., Kunz, P.L., Bodei, L., Hendifar, A.E., Mittra, E., Wolin, E.M., Yao, J.C., Pavel, M.E., Grande, E., Van Cutsem, E., Seregni, E., Duarte, H., Demange, A., Mutevelic, S., Krenning, E.P., Strosberg, J.R. |
---|---|
Zdroj: | In Annals of Oncology September 2021 32 Supplement 5:S911-S912 |
Databáze: | ScienceDirect |
Externí odkaz: |